Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
Sie sind hier:
Respirationstrakt
»
Neoplasie
15. November 2025
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift:
Rect Top
Anzeige
Seite 1 von 7624
Artikel 1 - 20 / 152476
Prognostic Impact of Body Mass index in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: An Updated Systematic Review and Meta-Analysis.
Technol Cancer Res Treat
Wang Z, Yang M, Zhao Y, Wang J, Tao M, Yang J, Mao J, Guo H, Zhu G, Yan X.
PMID: 41236792 [PubMed - indexed for MEDLINE]
Sinonasal Tract Osteochondromyxoma: Future Directions Beyond Morphologic Description.
Head Neck Pathol
Yang D, Wang G.
PMID: 41236678 [PubMed - indexed for MEDLINE]
Radiogenomics: transforming lung cancer care through non-invasive imaging and genomic integration.
Med Oncol
Shariaty F, Pavlov V.
PMID: 41236645 [PubMed - indexed for MEDLINE]
Neuron-tumor crosstalk fuels small cell lung cancer.
Trends Pharmacol Sci
Cao C.
PMID: 41235999 [PubMed - indexed for MEDLINE]
Efficacy and safety of combining bevacizumab and fractionated stereotactic radiotherapy for extensive brain metastases in patients with non-small cell lung cancer: a prospective phase II study (GASTO-1053).
Cancer Commun (Lond)
Zhou R, Zheng S, Wang D, Dong F, Zhang H, Zhang T, Luo Q, Liu B, Liu H, Zhang J, Liu F, Wang B, Chen L, Mou Y, Peng K, Qiu B, Liu H.
PMID: 41235462 [PubMed - as supplied by publisher]
Non-targeted metabolomics reveals diagnostic biomarker in the plasma of patients with lung cancer.
Oncol Lett
Liu Y, Li Y, Hou H, Dong Y, Tian H, Zhao Y, Li K, Zhou J, Song F, Li Y.
PMID: 41235360 [PubMed]
International cost-effectiveness analysis in osimertinib after chemoradiotherapy in stage III EGFR-mutated non-small cell lung cancer.
Front Public Health
Tang D, Zou X, Wei C, Zhang X.
PMID: 41235190 [PubMed - indexed for MEDLINE]
Study of non-surgical therapeutic patterns and prognosis in elderly patients with stage II non-small-cell lung cancer: an investigational study based on the SEER database.
Transl Cancer Res
Zhang L, Xu X, Gao Y.
PMID: 41234893 [PubMed]
Integration of single-cell and bulk transcriptomics to explore prognostic and immunotherapeutic characteristics of sodium overload-induced cell death in lung adenocarcinoma.
Transl Cancer Res
Shi Y, Qu X, Liu D, Zhang H, Wang S, Song J, Wang L, Wang W.
PMID: 41234862 [PubMed]
Advances and challenges in circulating tumor DNA-based early detection of lung cancer.
Transl Cancer Res
Yoon JK, Park JY, Kim YW, Oh HJ, Kim YC.
PMID: 41234819 [PubMed]
Development and validation of machine learning models for predicting STAS in stage I lung adenocarcinoma with part-solid and solid nodules: a two-center study.
Front Oncol
Ren QL, Lin L, Chu K, Xu XR, Wang HJ, Wu J, You JZ, Hu JX, Wang XL, Shu YS.
PMID: 41234731 [PubMed]
Fusion of CT radiomics and autoantibody biomarkers for enhanced prediction of lung cancer diagnosis: a comprehensive study.
Front Oncol
Xia X, Liu J, Du Y, Ma X, Zhou G, Yuan J, Hua Q, Wang L, Jiang H, He C, Liu C.
PMID: 41234728 [PubMed]
Evaluation of gefitinib alone or combined with bevacizumab in patients with EGFR L858R-positive advanced non-squamous non-small cell lung cancer: an open-label, randomized, phase 2 trial (BEVA-FLFX-001) with exploratory analysis of plasma biomarkers.
Transl Lung Cancer Res
Zhao X, Wu X, Wang H, Yu H, Sun S, Hu Z, Lin Y, Zhang Y, Yu B, Wu Z, Xiong K, Liu C, Wang S, Bao H, Ou Q, Wang J.
PMID: 41234598 [PubMed]
Fecal microbiota transplantation plus immune checkpoint inhibitor rechallenges in patients with advanced non-small cell lung cancer: a single-arm exploratory study.
Transl Lung Cancer Res
Du Y, Li Y, Yu M, Yu Y, Zhang Y, Wang X, He J, Lin L, Shen B, Gong Y, Zhu J, Zou B, Liu Y, Huang M, Lu Y.
PMID: 41234596 [PubMed]
Overall survival and progression-free survival of patients with non-small cell lung cancer and either limited or extensive synchronous metastatic spread in Germany-a population-based cancer registry cohort study.
Transl Lung Cancer Res
Bertram S, Schliemann A, Katalinic A, Kim-Wanner SZ, Pritzkuleit R, Twardella D, Waldmann A.
PMID: 41234592 [PubMed]
Local consolidative therapy for the primary tumor in EGFR-mutant advanced non-small cell lung cancer following osimertinib plus chemotherapy: a protocol for a single-arm, open-label, phase 2 trial.
Transl Lung Cancer Res
Kim MH, Seong H, Kim SH, Eom JS.
PMID: 41234591 [PubMed]
The role of TRPA1 in lung cancer.
Transl Lung Cancer Res
O'Connor D, Finn SP, Gray SG.
PMID: 41234585 [PubMed]
A retrospective cross-sectional study of FGFR2b alterations in Chinese patients with advanced squamous non-small cell lung cancer: prevalence, programmed death-ligand 1 co-expression patterns, and association with clinical outcomes.
Transl Lung Cancer Res
Wang X, Chi K, Wang H, Sun S, Ao C, Li J, Ge Y, Yang C, Fu Y, Lin D, Tang R, Sun W.
PMID: 41234584 [PubMed]
Immune-oncology-microbiome axis in lung cancer: from carcinogenesis to therapy-a narrative review.
Transl Lung Cancer Res
Shen M, Chen Y, Chen J, Yin J, Xu C, Wang D, Lv T.
PMID: 41234582 [PubMed]
Characterization of RET fusions via integrated DNA and RNA sequencing in early-stage non-small cell lung cancer: a retrospective study.
Transl Lung Cancer Res
Ding Y, Chen G, He X, Shi Y, He C, Yin JC, Zhang Z.
PMID: 41234581 [PubMed]
Artikel 1 - 20 / 152476
Seite 1 von 7624
Rect Bottom
Anzeige
Adserver Footer
Zeitfenster
--unbegrenzt--
1 Woche
1 Monat
3 Monate
6 Monate
1 Jahr
2 Jahre
3 Jahre
5 Jahre
10 Jahre
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Datenschutzerklärung / Privacy Policy
|
Werbung